Comparative evaluation of Semaphorin 4D, Peptidylarginine Deiminase 2 and Matrix Metalloproteinase-8 Gingival crevicular fluid levels in periodontally healthy, Severe periodontitis Smoker and non-smoker patients before and after Non-surgical periodontal therapy.

Dr Aishwarya Ikhar0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Group I: Periodontally healthy patients.
•Group II: Non-Smoker patients with untreated stage III periodontitis, with PPD more than equal to 5 mm and CAL more than equal to 4mm, BOP at >50% of sites (full mouth) and radiographic evidence of interproximal bone loss.
•Group III: Smoker patients with untreated stage III periodontitis, with PPD more than equal to 5 mm and CAL more than equal to 4mm, BOP at >50% of sites (full mouth) and radiographic evidence of interproximal bone loss.

•1.Patients who had received periodontal treatment within the last 6 months.
•2.Patients with any systemic diseases.
•3.Patients who had or are on immunosuppressive chemotherapy.
•4.Use of antibiotics within the last 6 months and anti-inflammatory drugs within the last 3 months.
•5.Pregnant and lactating females.

发起方

Dr Aishwarya Ikhar